Telbermin

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NameTelbermin
Drug Alias NameRecombinant VEGF165Recombinant VEGF-GenentechrhVEGF165Vascular endothelial growth factor 165-Genentech
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionVascular endothelial growth factor receptor stimulants
TargetsVascular endothelial growth factor receptor
Therapy Area/IndicationsFoot UlcerDiabetic Foot
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGenentech Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenentech Inc
Active IndicationsN/A
Inactive IndicationsFoot UlcerDiabetic Foot

Other Information

ATC CodeN/A
Related LinksN/A